Navigation Links
Bioabsorbable Stents - Global Strategic Business Report - 2013 Profiles 16 Companies inside the Market
Date:6/7/2013

DUBLIN, June 7, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/j6pgb5/bioabsorbable) has announced the addition of the "Bioabsorbable Stents - Global Strategic Business Report" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


This report analyzes the worldwide markets for Bioabsorbable Stents in Thousand Units. The report provides separate comprehensive analytics for the US, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2018. The report profiles 16 companies including many key and niche players such as Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, BIOTRONIK SE & Co. KG, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., and REVA Medical, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary

1. INDUSTRY OVERVIEW

2. PRODUCT OVERVIEW

3. PRODUCT LAUNCH/INTRODUCTION
4. RECENT INDUSTRY ACTIVITY

5. FOCUS ON SELECT GLOBAL PLAYERS

6. GLOBAL MARKET PERSPECTIVE

III. MARKET

1. THE UNITED STATES

2. EUROPE
3. ASIA-PACIFIC
4. REST OF WORLD

IV. COMPETITIVE LANDSCAPE


Companies Mentioned

- 3D Biotek LLC (USA)
- Abbott Laboratories (USA)
- Abbott Vascular (USA)
- Amaranth Medical, Inc. (USA)
- Arterial Remodeling Technologies SA (France)
- Arterius Ltd. (UK)
- Biotronik SE & Co., KG (Germany)
- Elixir Medical Corporation (USA)
- Kyoto Medical Planning Co., Ltd. (Japan)
- OrbusNeich (Hong Kong)
- REVA Medical, Inc. (USA)
- S3V Vascular Technologies Pvt., Ltd. (India)
- Sahajanand Medical Technologies Pvt., Ltd. (India)
- Stron Medical (Germany)
- Tepha, Inc. (USA)
- Xenogenics Corporation (USA)
- Zorion Medical (USA)


For more information visit http://www.researchandmarkets.com/research/j6pgb5/bioabsorbable

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Sector: Cardiovascular Devices


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. OrbusNeich Launches Worlds First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents
2. Peripheral Vascular Devices Market (Peripheral Vascular Stents, PTA Balloon Catheters, Guidewires, IVC Filters, Atherectomy, Chronic Total Occlusion, Embolic Protection Devices, Synthetic Surgical Grafts, Aortic Stents) - Global Industry Analysis, S
3. Global Vascular Stents Market 2012-2016
4. Drug-coated stents prevent leg amputation
5. Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents
6. U.S. Physician Survey: Stents by Brand, Length, Diameter, Type and Coating 2012
7. Global Drug-Eluting Stents Industry
8. Lexicon To Present At The Goldman Sachs Global Healthcare Conference
9. BD to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
10. Quest Diagnostics CEO Steve Rusckowski Reaffirms Full-Year 2013 Guidance At The Jefferies 2013 Global Healthcare Conference
11. Frost & Sullivan: Standardized Regulations Crucial for Growth in Global Dimensional Metrology Market for Medical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is ... emergency ambulance transport experience for the millions of people who require these medical ... the taxi industry through the use of technology. Now, SmartEMS has put forth ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
Breaking Medicine News(10 mins):